S&P 500   4,117.86 (-1.11%)
DOW   33,949.01 (-0.61%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
S&P 500   4,117.86 (-1.11%)
DOW   33,949.01 (-0.61%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
S&P 500   4,117.86 (-1.11%)
DOW   33,949.01 (-0.61%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
S&P 500   4,117.86 (-1.11%)
DOW   33,949.01 (-0.61%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
NASDAQ:IRMD

IRadimed - IRMD Stock Forecast, Price & News

$35.92
-1.43 (-3.83%)
(As of 02/8/2023 05:18 PM ET)
Add
Compare
Today's Range
$35.34
$37.84
50-Day Range
$27.80
$42.14
52-Week Range
$26.00
$55.92
Volume
78,539 shs
Average Volume
44,163 shs
Market Capitalization
$451.51 million
P/E Ratio
35.22
Dividend Yield
N/A
Price Target
$48.00

IRadimed MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
34.1% Upside
$48.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
0.40mentions of IRadimed in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$28,550 Sold Last Quarter
Proj. Earnings Growth
17.09%
From $1.17 to $1.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.56 out of 5 stars

Medical Sector

81st out of 1,029 stocks

Surgical & Medical Instruments Industry

8th out of 105 stocks

IRMD stock logo

About IRadimed (NASDAQ:IRMD) Stock

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Stock News Headlines

IRadimed (NASDAQ:IRMD) PT Raised to $48.00
New Years, New Ways To Trade!
If you’ve been considering options trading but don’t know where to start, trading champion Chuck Hughes’ coveted guide, “Options Trading Made Easy” is for you! Free for a limited time, this guide could help 2023 become your most profitable year yet! Click here for a free copy now! pixel
IRadimed (IRMD) Q4 Earnings Top Estimates
IRadimed (IRMD) Scheduled to Post Quarterly Earnings on Thursday
New Years, New Ways To Trade!
If you’ve been considering options trading but don’t know where to start, trading champion Chuck Hughes’ coveted guide, “Options Trading Made Easy” is for you! Free for a limited time, this guide could help 2023 become your most profitable year yet! Click here for a free copy now! pixel
IRadimed Third Quarter 2022 Earnings: Beats Expectations
3 REITs With Dividends Above 8% - Yahoo Finance
See More Headlines
Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Company Calendar

Last Earnings
10/28/2021
Today
2/08/2023
Ex-Dividend for 2/21 Dividend
2/10/2023
Dividend Payable
2/21/2023
Next Earnings (Estimated)
5/05/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRMD
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$48.00
High Stock Price Forecast
$48.00
Low Stock Price Forecast
$48.00
Forecasted Upside/Downside
+33.6%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$12.83 million
Pretax Margin
29.00%

Debt

Sales & Book Value

Annual Sales
$53.30 million
Cash Flow
$0.78 per share
Book Value
$5.85 per share

Miscellaneous

Free Float
7,075,000
Market Cap
$451.51 million
Optionable
Not Optionable
Beta
1.07

Key Executives

  • Roger Susi
    Chairman, President & Chief Executive Officer
  • John F. Glenn
    Chief Financial Officer
  • Chris Williamson
    Vice President-Information Technology
  • Lynn Neuhardt
    Vice President-Research & Development
  • Randy Waddell
    VP-Worldwide Sales & Marketing













IRMD Stock - Frequently Asked Questions

What is IRadimed's stock price forecast for 2023?

0 Wall Street research analysts have issued 1 year price objectives for IRadimed's stock. Their IRMD share price forecasts range from $48.00 to $48.00. On average, they predict the company's stock price to reach $48.00 in the next year. This suggests a possible upside of 28.5% from the stock's current price.
View analysts price targets for IRMD
or view top-rated stocks among Wall Street analysts.

How have IRMD shares performed in 2023?

IRadimed's stock was trading at $28.29 at the beginning of 2023. Since then, IRMD stock has increased by 32.0% and is now trading at $37.35.
View the best growth stocks for 2023 here
.

When is IRadimed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023.
View our IRMD earnings forecast
.

How were IRadimed's earnings last quarter?

IRadimed Co. (NASDAQ:IRMD) announced its quarterly earnings results on Thursday, October, 28th. The medical equipment provider reported $0.23 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.06. The medical equipment provider earned $10.91 million during the quarter, compared to the consensus estimate of $10.39 million. IRadimed had a trailing twelve-month return on equity of 19.35% and a net margin of 23.99%. During the same period last year, the company earned $0.09 EPS.

How often does IRadimed pay dividends? What is the dividend yield for IRadimed?

IRadimed declared a dividend on Monday, February 6th. Shareholders of record on Monday, February 13th will be given a dividend of $1.05 per share on Tuesday, February 21st. This represents a dividend yield of 2.54%. The ex-dividend date of this dividend is Friday, February 10th. This is a positive change from the stock's previous dividend of $1.00.
Read our dividend analysis for IRMD
.

What guidance has IRadimed issued on next quarter's earnings?

IRadimed issued an update on its fourth quarter 2022 earnings guidance on Wednesday, January, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $14.90 million-$14.90 million, compared to the consensus revenue estimate of $14.63 million.

What other stocks do shareholders of IRadimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

What is IRadimed's stock symbol?

IRadimed trades on the NASDAQ under the ticker symbol "IRMD."

Who are IRadimed's major shareholders?

IRadimed's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Russell Investments Group Ltd. (1.61%), Rice Hall James & Associates LLC (0.58%), Los Angeles Capital Management LLC (0.10%), Calamos Advisors LLC (0.10%), Navellier & Associates Inc. (0.07%) and Allspring Global Investments Holdings LLC (0.02%). Insiders that own company stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, James B Hawkins, Louis S Waldman, Monty K Allen, Monty K Allen and Roger E Susi.
View institutional ownership trends
.

How do I buy shares of IRadimed?

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IRadimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $37.35.

How much money does IRadimed make?

IRadimed (NASDAQ:IRMD) has a market capitalization of $469.49 million and generates $53.30 million in revenue each year. The medical equipment provider earns $12.83 million in net income (profit) each year or $1.02 on an earnings per share basis.

How many employees does IRadimed have?

The company employs 110 workers across the globe.

How can I contact IRadimed?

IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037.

This page (NASDAQ:IRMD) was last updated on 2/8/2023 by MarketBeat.com Staff